Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review
Angela Raffaella Losito, Francesca Raffaelli, Paola Del Giacomo, et al.
Antibiotics (2022) Vol. 11, Iss. 5, pp. 579-579
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

A review of the mechanisms that confer antibiotic resistance in pathotypes of E. coli
Sina Nasrollahian, Jay P. Graham, Mehrdad Halaji
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 39
The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan”
Giuseppe Mancuso, Silvia De Gaetano, Angelina Midiri, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 1912-1912
Open Access | Times Cited: 40
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments
F Giovagnorio, Andrea De Vito, Giordano Madeddu, et al.
Antibiotics (2023) Vol. 12, Iss. 11, pp. 1621-1621
Open Access | Times Cited: 27
Mechanisms of Antibiotic and Biocide Resistance That Contribute to Pseudomonas aeruginosa Persistence in the Hospital Environment
Cláudia Verdial, Isa Serrano, Luís Tavares, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1221-1221
Open Access | Times Cited: 25
Call for next-generation drugs that remove the uptake barrier to combat antibiotic resistance
Bo Peng, Hui Li, Xuan‐xian Peng
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103753-103753
Closed Access | Times Cited: 23
Extensively and multidrug-resistant bacterial strains: case studies of antibiotics resistance
Bandar Almutairy
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 11
Novel PiuC, PirA, and PiuA mutations leading to in vivo cefiderocol resistance progression in IMP-16- and KPC-2-producing Pseudomonas aeruginosa from a leukemic patient
Joaquim Viñes, Sabina Herrera, Andrea Vergara, et al.
Microbiology Spectrum (2025)
Open Access | Times Cited: 1
Microbial Biofilm Formation to Mitigate Foodborne Pathogens Strategies and Control Measures
Meshari A. Alsuwat, Assar Ali Shah, Shakeeb Ullah, et al.
Indian Journal of Microbiology (2025)
Closed Access | Times Cited: 1
Molecular and biological characterization of pyocyanin from clinical and environmental Pseudomonas aeruginosa
Heba Shouman, Heba Shehta Said, Hany I. Kenawy, et al.
Microbial Cell Factories (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of Pseudomonas aeruginosa
Ashish Kothari, RADHIKA SUNIL KHERDEKAR, Vishal Mago, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1230-1230
Open Access | Times Cited: 16
Beyond antibiotics: Emerging antivirulence strategies to combat Pseudomonas aeruginosa in cystic fibrosis
Umang Mudgil, Lavanya Khullar, Jatin Chadha, et al.
Microbial Pathogenesis (2024) Vol. 193, pp. 106730-106730
Open Access | Times Cited: 7
Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination
George G. Zhanel, Celine Mansour, Stacey Mikolayanko, et al.
Drugs (2024) Vol. 84, Iss. 10, pp. 1219-1250
Closed Access | Times Cited: 6
Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients
Helen Giamarellou, Ilias Karaiskos
Antibiotics (2022) Vol. 11, Iss. 8, pp. 1009-1009
Open Access | Times Cited: 25
Compassionate use of a novel β-lactam enhancer-based investigational antibiotic cefepime/zidebactam (WCK 5222) for the treatment of extensively-drug-resistant NDM-expressing Pseudomonas aeruginosa infection in an intra-abdominal infection-induced sepsis patient: a case report
Dilip Dubey, Manish Roy, Tajamul Hussain Shah, et al.
Annals of Clinical Microbiology and Antimicrobials (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review
Alberto Corona, Vincenzo De Santis, Andrea Agarossi, et al.
Antibiotics (2023) Vol. 12, Iss. 8, pp. 1262-1262
Open Access | Times Cited: 16
Drug combinations for inhalation: Current products and future development addressing disease control and patient compliance
Heba Banat, Rita Ambrus, Ildikó Csóka
International Journal of Pharmaceutics (2023) Vol. 643, pp. 123070-123070
Closed Access | Times Cited: 15
Recent trends and challenges to overcome Pseudomonas aeruginosa infections
Alessandra Ammazzalorso, Arianna Granese, Barbara De Filippis
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 6, pp. 493-509
Closed Access | Times Cited: 5
Intravenous Fosfomycin: A Potential Good Partner for Cefiderocol. Clinical Experience and Considerations
Andrea Marıno, Stefano Stracquadanio, Edoardo Campanella, et al.
Antibiotics (2022) Vol. 12, Iss. 1, pp. 49-49
Open Access | Times Cited: 22
99mTc-Labeled, Colistin Encapsulated, Theranostic Liposomes for Pseudomonas aeruginosa Infection
Merve Karpuz, Aybala Temel, Emre Özgenç, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 3
Closed Access | Times Cited: 11
Registry-Based Retrospective Cohort Study of Mortality among Adults Admitted to Intensive Care Units in Istanbul with Hospital Acquired Pseudomonas aeruginosa Bloodstream-Infection between 2014–2021
Okan Derin, Meyha Şahin, Rıdvan Dumlu, et al.
Antibiotics (2024) Vol. 13, Iss. 1, pp. 90-90
Open Access | Times Cited: 4
Risk Factors and Outcomes of Multidrug-resistant Pseudomonas aeruginosa in Kelantan, Malaysia: A Multicenter Case–control Study
Safa Salim, Natasha Din, R. Rashid, et al.
Saudi Journal of Medicine and Medical Sciences (2025) Vol. 13, Iss. 1, pp. 18-25
Open Access
Endophytic fungi isolated from Vietnamese Nut grass (Cyperus rotundus L. Cyperaceae) – A promising solution to mitigate the prime phenomenon of antibiotic resistance
Bac V.G. Nguyen, Linh X.T. Tran, Anh-Tu Ha-Nguyen, et al.
Heliyon (2025), pp. e41920-e41920
Open Access
Biofilm formation and analysis of EPS architecture comprising polysaccharides and lipids by Pseudomonas aeruginosa and Escherichia coli on food processing surfaces
Shirin Akter, Md. Ashikur Rahman, Md. Ashrafudoulla, et al.
Food Research International (2025), pp. 116274-116274
Closed Access
An Assessment Of Cefiderocol's Synergistic Effects With Eravacycline, Colistin, Meropenem, Levofloxacin, Ceftazidime/avibactam, And Tobramycin Against Carbapenem-Resistant and -Susceptible Pseudomonas aeruginosa
Emel Mataracı Kara, Bekir Özer, Mesut Yılmaz, et al.
Microbial Pathogenesis (2025), pp. 107560-107560
Closed Access
Bioinformatics and Genomic Analyses of the Suitability of Eight Riboswitches for Antibacterial Drug Targets
Nikolet Pavlova, Robert Penchovsky
Antibiotics (2022) Vol. 11, Iss. 9, pp. 1177-1177
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top